BCM
Bayesian Capital Management’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $476K | Sell |
6,900
-5,500
| -44% | -$380K | 0.08% | 294 |
|
|
2025
Q1 | $861K | Sell |
12,400
-12,500
| -50% | -$868K | 0.14% | 200 |
|
|
2024
Q4 | $2.14M | Buy |
+24,900
| New | +$2.14M | 0.26% | 112 |
|
|
2024
Q1 | – | Sell |
-3,630
| Closed | -$376K | – | 1013 |
|
|
2023
Q4 | $376K | Buy |
+3,630
| New | +$376K | 0.04% | 449 |
|
|
2023
Q1 | – | Sell |
-19,358
| Closed | -$2.62M | – | 1003 |
|
|
2022
Q4 | $2.62M | Buy |
19,358
+12,400
| +178% | +$1.68M | 0.38% | 37 |
|
|
2022
Q3 | $693K | Buy |
6,958
+4,200
| +152% | +$418K | 0.14% | 201 |
|
|
2022
Q2 | $307K | Buy |
2,758
+558
| +25% | +$62.1K | 0.06% | 475 |
|
|
2022
Q1 | $244K | Buy |
+2,200
| New | +$244K | 0.04% | 593 |
|
|
2021
Q4 | – | Sell |
-3,427
| Closed | -$329K | – | 478 |
|
|
2021
Q3 | $329K | Buy |
+3,427
| New | +$329K | 0.1% | 248 |
|
|
2017
Q4 | – | Sell |
-41,838
| Closed | -$2.01M | – | 669 |
|
|
2017
Q3 | $2.01M | Buy |
41,838
+6,100
| +17% | +$294K | 0.48% | 47 |
|
|
2017
Q2 | $1.53M | Buy |
+35,738
| New | +$1.53M | 0.57% | 34 |
|